The LoMP trial being run by the University Hospital Ghent, Belgium, reported the outcomes of cytoreductive radical prostatectomy (cRP) vs standard of care.
The hypothesis that cRP will decrease the number of local events in the context of oligometastatic prostate cancer is attractive, but has been not structurally addressed. From 2014-2018, 80 asymptomatic patients were prospectively included in the LoMP trial. cRP was performed in patients with a resectable tumour who were fit to undergo surgery (n=40). Standard of care was administered to patients who were ineligible or unwilling to undergo cRP (n=40), so there was definitely a surgical selection bias in the cohort. The 2-year estimates for overall survival were 92% vs 64% (P=0.003) in favour of cRP; likewise, the 2-year estimate for local event-free survival were 89% vs 58% (P=0.001) in favour of cRP. Although imperfect in study design, these data will be very useful in further exploration of the application of cRP in selected patients.
« Gene expression signatures Next Article
Spanish study directly links surgical volume with mortality in bladder cancer patients undergoing cystectomy »
Table of Contents: EAU 2019
Renal Transplantation and Renal Cell Carcinoma
Lower Urinary Tract Symptoms
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.